Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data
|
|
- Jodie Patrick
- 5 years ago
- Views:
Transcription
1 Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data Quan Chen, Eric Tai, Shayne Gallaway, Sherri L. Stewart, Thomas Tucker, Jaclyn Nee, Bin Huang 2018 NAACCR June 14 Pittsburgh, PA
2 Background Cigarette smoking status is an important factor for population-based cancer outcome research. Smoking causes cancers of the lung, pancreas, colon, and rectum etc. In 2011, 221,130 new cases of lung cancer occurred, 90% of which were attributable to smoking Smoking not only cause cancers, but is also associated with comorbidity status and survival for cancer patients. COPD, heart disease, stroke, TB. Due to limited resources, smoking history is either not well captured or not at all in population-based cancer registry data.
3 Background Cont. Kentucky Cancer Registry (KCR) data linkage projects Link KCR ( ) with claims from SEER*Medicare( ), Medicaid( ), private insurance groups( ) Probabilistic linkage and manual review Six cancer types: Lung, Colorectal, Breast, Pancreatic, Ovary, and Prostate Augmenting results: Treatments: Chemotherapy, Radiotherapy, Hormone therapy; Comorbidities Smoking History
4 Research Aim Examining the feasibility to augment smoking history in the registry data with health administrative claims Examining the prevalence of smoking and smoking cessation among tobacco related cancers (TRC) and non tobacco related cancers (ntrc) TRC: Lung, Colorectal, and Pancreatic ntrc: Breast, Ovary, and Prostate
5 Methods Linked Kentucky cancer cases diagnosed in were included in this study. Smoking history in KCR data were captured as Cigarette Pack Years Tobacco history 0 Never used Non-Smoker 1 Cigarette smoker 2 Cigar/pipe smoker 3 Snuff/chew/smokeless tobacco user 4 Mixed use of more than one type of tobacco product Smoker 5 E-cigarettes 6 E-cigarettes plus another type of tobacco product 9 Not recorded/unknown Unknown
6 Methods Cont. Smoking history in Claims data was calculated by identifying ICD and CPT codes of personal history of tobacco use or disorder, and smoking cessation and counseling HCPCS/CPT: G0436 G0437 G0375 G0376 S9075 S9453 ICD: x V15.82
7 Methods Cont. The following algorithm was used to augment the smoking history in KCR : Limited the claims within 12 months before cancer diagnosis. If smoking history in KCR was either Non Smoker or Unknown, and claims captured smoking history information, then KCR data was augmented as Smoker. Smoking cessation (counseling or pharmacotherapy) were captured based on claims within 12 months before or 12 months after cancer diagnosis. Nicotine replacement therapy (NRT) Bupropion (Zyban, Wellbutrin ) Varenicline (Chantix )
8 Results- Smoking History for TRC Cancer Type # of Patient s KCR Smoker Claims Smoker Both Sources Augmented Data N % N % N % N % TRC Lung Colorect al Pancrea s % % % % % % % % % % % % % % % %
9 Results- Smoking History for ntrc Cancer Type # of Patient s KCR Smoker Claims Smoker Both Sources Augmented Data N % N % N % N % NTRC Breast Ovary Prostate % % % % % % % % % % % % % % % %
10 Results - % Extra smokers captured by health claims data 30% 23% 21% 15% 15% 8% 10% 8% 11% 10% 8% 12% 0% TRC Colorectal NTRC Ovary
11 Results - Smoking cessation counseling usage identified through claims Cancer Smokers identifie d in Claims Pre-Dx Post-Dx Pre and Post - Dx N % N % N % N % TRC % % % % Lung % % % % Colorecta 2.14% 2 l % 0.24% % Pancreas % % % % N-TRC % % % % Breast % % % % Ovary % % % % Prostate % % % % All
12 Results - Smoking related pharmacotherapy usage identified through claims Cancer Smokers identifie d in Claims Pre-Dx Post-Dx Pre and Post - Dx All N % N % N % N % TRC % % % % Lung % % % % Colorecta % 5.69% l % % 48 Pancreas % % % % NTRC % % % % Breast % % % % Ovary % % % % Prostate % % % %
13 Global Moran's I Spatial Autocorrelation High-High Counties with high smoking prevalence surrounded by counties with high smoking prevalence High-Low Low-High Low-Low
14 Summary Health administrative claims data are good sources to improve cancer registry data on smoking history. Smoking history information have been augmented about 10% for both TRC and ntrc patients. Comparing to ntrc, TRC patients were more likely to have history of smoking (64.3% vs. 40.0%) although the differences mainly come from lung cancer.
15 Summary Cont. The large percentages of smokers in ntrc reflects the high smoker rates in the background population BRFSS- KY 29% smoking rate, 1 st in US In Kentucky, only 6.4% of lung cancer patients had post diagnosis smoking cessation counseling and 4.5% of them received pharmacotherapy. Studies have found that tobacco cessation usage among lung cancer patients after diagnosis may increase overall survival by 9 months.
16 Acknowledgement Funding Support: CDC U48DP SIP NCI SEER HHSN
17 Thank you! Quan Chen, University of Kentucky
Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky
Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative
More informationUtilization of OncoType DX Test for
Utilization of OncoType DX Test for Breast Cancer in the Community Setting XC Wu, XR Li, V Petkov, MC Hsieh, M Loch, PA Andrews, VW Chen 2016 NAACCR Annual Conference June 8, 2016 Background Chemotherapy
More informationThe Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2006
The Kentucky Department for Public Health University of Kentucky College of Nursing Local Tobacco Cessation Survey, 2006 Health Department Report prepared through a contract between the Kentucky Cabinet
More informationSlide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today
Slide 1 UNIVERSITY OF HAWAI I CANCER CENTER Reducing Tobacco Use and Nicotine Dependence in Clinical Settings Pebbles Fagan, Ph.D., M.P.H. Associate Professor and Program Director Cancer Prevention and
More informationThe Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007
The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007 District Health Department Report prepared through a contract
More informationA New Measure to Assess the Completeness of Case Ascertainment
A New Measure to Assess the Completeness of Case Ascertainment Barnali Das, Ph.D. Linda Pickle, Ph.D. Eric J. (Rocky) Feuer, Ph.D. Lin Clegg, Ph.D. Surveillance Research Program, National Cancer Institute
More informationPotentially preventable cancers among Alaska Native people
Potentially preventable cancers among Alaska Native people Sarah Nash Cancer Surveillance Director, Alaska Native Tumor Registry Diana Redwood, Ellen Provost Alaska Native Epidemiology Center Cancer is
More informationTobacco Use Dependence and Approaches to Treatment
University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Tobacco Use Dependence and Approaches to Treatment Audrey Darville University of Kentucky, audrey.darville@uky.edu Chizimuzo
More informationBest Practices in Tobacco Treatment IDN
Best Practices in Tobacco Treatment IDN 6.27.18 Objectives Project SCUM was a plan proposed in 1995 by R. J. Reynolds Tobacco Company (RJR) to sell cigarettes to members of the "alternative lifestyle"
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 4005-2 Program Health Care Reform Tobacco Cessation Supply Limit (Therapy Duration) Override Kentucky Fully Insured Medication
More informationSample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits
Technical Assistance Tool October 2017 Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits C ross-agency Medicaid-Public Health teams interested
More informationHelping Employees Break the Habit
Helping Employees Break the Habit May 28, 2014 Diane Andrea, RD, LD Wellness Consultant Surgeon General s Report on Smoking and Health 1964 Report first issued, 42% of Americans smoke 1966 Required warning
More informationMeasure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use
Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use 2010 PQRI REPTING OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years or older who
More informationSmoking Cessation Strategies: What Works?
Smoking Cessation Strategies: What Works? Andrew M. Busch, Ph.D. Centers For Behavioral and Preventive Medicine The Miriam Hospital Department of Psychiatry and Human Behavior Alpert Medical School of
More informationHealth Promotion, Screening, & Early Detection
OCN Test Content Outline 2018 Health Promotion, Screening, & Early Detection Kelley Blake MSN, RN, AOCNS, OCN UW Medicine/Valley Medical Center I. Care Continuum 19% A. Health promotion & disease prevention
More informationCANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
More informationHow to help your patient quit smoking. Christopher M. Johnson MD, PhD
How to help your patient quit smoking Christopher M. Johnson MD, PhD Outline Smoking and its effects on IBD CD UC Clinical interventions Pharmacotherapy Resources Outline Smoking and its effects on IBD
More informationIntroduction to pharmacotherapy
Introduction to pharmacotherapy Dr. Shamim Jubayer. Research Fellow Dept. Epidemiology and Research National Heart Foundation Hospital And research Institute Effective tobacco cessation medications The
More informationManagement of Perinatal Tobacco Use
Management of Perinatal Tobacco Use David Stamilio, MD, MSCE Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, UNC School of Medicine Funding for this project is provided in
More informationGary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017
Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017 Presentation Overview Background Methods Results Conclusions 2 1 Background Increase physician reporting Capture missing first course treatment Capture
More informationProject TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.
Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Prevalence of Smoking and Cessation During Pregnancy In 2014, 14% in women with Medicaid coverage versus 3.6% of women with
More informationWelcome ACoS Brainstorming Webinar
Welcome ACoS Brainstorming Webinar Dr. Youjie Huang DOH CER PI Dr. Jill MacKinnon FCDS Project Director Dr. Monique Hernandez FCDS CER Project Manager Mike Thiry FCDS Manager for Data Acquisition Steve
More informationCERCIT Workshop: Texas Cancer Registry; Medicaid; Registry Linked Claims Data
CERCIT Workshop: About the Data: Texas Cancer Registry; Medicaid; Registry Linked Claims Data MelanieWilliams,PhD,Manager, Texas Cancer Registry Melanie Williams, PhD, Manager, Texas Cancer Registry Cheryl
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of
More informationLeveraging Electronic Pathology Reporting in Cervical Cancer Epidemiology: Determinants of Invasive Diagnoses in Kentucky
Leveraging Electronic Pathology Reporting in Cervical Cancer Epidemiology: Determinants of Invasive Diagnoses in Kentucky Presented by: Eric B. Durbin, DrPH, MS Director of Cancer Informatics Kentucky
More informationAdolescents and Tobacco Cessation
Adolescents and Tobacco Cessation Jonathan D. Klein, MD, MPH American Academy of Pediatrics Julius B. Richmond Center and the University of Rochester Rochester, NY Goal To review current evidence and perspectives
More informationSociodemographic and Clinical Predictors of Triple Negative Breast Cancer
University of Kentucky UKnowledge Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.) College of Public Health 2017 Sociodemographic and Clinical Predictors of Triple Negative Breast Cancer Madison
More informationNicotine Replacement and Smoking Cessation: Update on Best Practices
Nicotine Replacement and Smoking Cessation: Update on Best Practices Adrienne Duckworth, MSN, APRN, FNP-C, CTTS Section of Hematology/Oncology WVU Department of Medicine WVU Cancer Institute Objective
More informationSmoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation
Smoking Cessation MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Objectives Tobacco use at population level Tobacco use and control around the world What works for managing tobacco use Common myths
More informationMaking Your Business Tobacco Free
Making Your Business Tobacco Free May 19, 2016 Adrienne Rollins, MPA CPS Tobacco Use Prevention Manager Oklahoma State Department of Health Objectives: Tobacco-Free Policy Good for Business Participants
More informationClasses and Quitlines and Patches, Oh My! Tobacco Use Why it is Your Business. Deirdre Sullivan, Health Educator
Classes and Quitlines and Patches, Oh My! Tobacco Use Why it is Your Business Deirdre Sullivan, Health Educator Why Tobacco? Smoking is the leading cause of preventable death and disability in the United
More informationComplete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting
Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Eric B. Durbin, DrPH, MS, Director of Cancer Informatics Frances E. Ross, CTR,
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table
More informationSmoking Cessation: Where Are We Now? Nancy Rigotti, MD
Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for
More informationSmoking Cessation: Treating Tobacco Dependence
Smoking Cessation: Treating Tobacco Dependence Pat Folan, RN Center for Tobacco Control Pulmonary Medicine NS-LIJ Health System NYS DOH Tobacco Control Program Treating Tobacco Dependence Center for Tobacco
More informationTobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare
Tobacco Cessation: Best Practices in Cancer Treatment Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare Objectives 1. Describe the current state of tobacco use treatment
More information2014 Oncology Measures Group Overview
2014 Oncology Measures Group Overview The Oncology Measures Group is a reporting option that significantly reduces the burden of participation in the Physician Quality Reporting System (PQRS). Source:
More information7/29/2014. FCDS Annual Meeting July 24-25, 2014 Caribe Royale Resort Orlando, Florida
FCDS Annual Meeting July 24-25, 2014 Caribe Royale Resort Orlando, Florida Data collected by central cancer registries is utilized for patient outcomes research Requires complete detailed treatment data
More informationBILLING GUIDE FOR TOBACCO SCREENING AND CESSATION
Tobacco use status is now embedded in most of the major electronic health records and evidence-based tobacco cessation counseling and pharmacotherapy covered by Medicare, Medicaid and most private health
More informationQuitting smoking is hard
Quitting smoking is hard About 2 out of 3 of smokers say they want to quit About half try to quit each year, but few succeed without help Smokers become physically dependent on nicotine, but there s also
More informationPeripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment
Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Prepared and Presented by Jon Manocchio, Pharm D Blanchard Valley Hospital October 2011 Introduction PAD is a condition that is
More informationAnnual Report. Kentucky Cancer Registry. Includes a Special Report: Colorectal Cancer in Kentucky
Kentucky Cancer Registry December 2008 Annual Report Cancer Incidence and Mortality in Kentucky, 2001-2005 Includes a Special Report: Colorectal Cancer in Kentucky ACKNOWLEDGEMENTS The population-based
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 2045-9 Program Prior Authorization/HCR- Tobacco Cessation - Health Care Reform Medication Bupropion SR (generic Zyban), Chantix
More informationRI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits
RI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits Purpose: To collect data from each health plans fully insured accounts for policies issued in RI to insured members regardless of where
More informationWhat is Quitline Iowa?
CONTENTS: What is Quitline Iowa? 0 A telephone counseling helpline for tobacco-use cessation. Free to all residents of the state of Iowa Open Monday-Thursday 7:00am 12:00am / Friday 7:00am 9:00pm / Saturday
More informationFlorida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
More informationTobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing GOAL To build the capacity of prescribing clinicians in behavioral health settings to integrate best practices for prescribing
More informationEvaluation of the Workplace-based Quit Smoking Programs. Intake Survey
Evaluation of the Workplace-based Quit Smoking Programs Intake Survey Information about You and Your Smoking Please check your answer or write your answer in the spaces provided. PLEASE COMPLETE - Your
More informationSummary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals
Summary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals Talk with patients about ü Cancer Prevention & Early Detection ü Benefits, harms
More informationCriteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer
Lung Cancer Screening Guidelines with low- dose computed tomography (LDCT): USPSTF and CMS February 6, 2015 Kentucky Cancer Consortium and Kentucky LEADS Component 3 Jennifer Redmond Knight, DrPH, jredknight@kycancerc.org
More informationTobacco Control Highlights Wisconsin
Tobacco Control Highlights Wisconsin Health Consequences and Costs Smoking - Attributable Mortality (SAM), 2000-2004 Smoking - Attributable Productivity Losses, 2000-2004 Smoking - Attributable Expenditures
More informationPANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD
PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.
More informationTobacco Control Highlights Alaska
Tobacco Control Highlights Alaska Health Consequences and Costs Smoking - Attributable Mortality (SAM), 2000-2004 Smoking - Attributable Productivity Losses, 2000-2004 Smoking - Attributable Expenditures
More informationEffective Treatments for Tobacco Dependence
Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for
More informationWhat is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*
What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases
More informationHIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA
HIV and Aging Making Tobacco Cessation a Priority in HIV/AIDS Services June 27, 2008 Amanda Brown, MPH Ruth Tripp, MPH, RN Objectives To explore existing knowledge of the HIV and smoking connection. To
More informationAdvancing Health Equity in Lung Cancer Outcomes
Advancing Health Equity in Lung Cancer Outcomes Edwin J Jackson Jr. DO Pulmonary and Critical Care Medicine Disclosures Funding: American Thoracic Society 2 1 Lecture Outline Cancer Disparities Smoking
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationSmoking Cessation. Samer Kanaan, M.D.
Smoking Cessation Samer Kanaan, M.D. Goals Understand the Societal impact of Smoking Smoking Cessation: The 5 A Model - Ask, Advise, Assess, Assist, Arrange Review The Stages of Change Review smoking cessation
More informationCessation Medicine Reference Guide Table of Contents
Cessation Medicine Reference Guide Table of Contents 1. Patch 2. Nicotine Gum 3. Nicotine Lozenge 4. Inhaler 5. Nasal Spray 6. Bupropion SR (Zyban) 7. Chantix (Varenicline) Patch Typical course of therapy
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2045-6 Program Prior Authorization/HCR- Tobacco Cessation - Health Care Reform Medication Bupropion SR (generic Zyban), Chantix
More informationDevelopment, Implementation, and Dissemination of the Nurse-Administered Tobacco Tactics Intervention
Development, Implementation, and Dissemination of the Nurse-Administered Tobacco Tactics Intervention Sonia A. Duffy, PhD, RN, FAAN The Ohio State University, College of Nursing and the VA Ann Arbor Healthcare
More informationTotal Health Quality Indicators For Providers 2017
Well Adult Well Visit 20 yrs > Yearly 99385-87, 99395-97, G0402, G0438, G0439, G0463 Total Health Quality Indicators For Providers 2017 Adult- Preventive Z00.00 Report ALL components of an annual visit
More informationDecoding the USPSTF. By: Dr Vikram Arora Heritage Valley Health System
Decoding the USPSTF By: Dr Vikram Arora Heritage Valley Health System Objectives O Gain insight into function of USPSTF O Review grading system O Critically appraise key current recommendations of the
More informationTrends in electronic cigarette use in England
Trends in electronic cigarette use in England Robert West Jamie Brown Emma Beard University College London Updated 14 th April 215 Background Electronic cigarette use has become prevalent in many countries
More informationCancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018
Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018 Tim Cowan, MSPH Director, Data Reporting and Evaluation Center for Health Improvement MaineHealth All Cancer Mortality
More informationTO ONE S SELF, OTHERS,& ENVIRONMENT
SMOKING IS A HEALTH DESTRUCTIVE HABIT TO ONE S SELF, OTHERS,& ENVIRONMENT EVERY SMOKER SHOULD BE OFFERED TREATMENT TO QUIT Juliette Jibrail Juliette Jibrail Nov. 11, 2007 Thorough Internet Search Variety
More informationThe Science and Practice of Perinatal Tobacco Use Cessation
1 The Science and Practice of Perinatal Tobacco Use Cessation Erin McClain, MA, MPH Catherine Rohweder, DrPH Cathy Melvin, PhD, MPH erin_mcclain@unc.edu Prevention of Tobacco Use and Secondhand Smoke Exposure
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Derbyshire Formulary for Nicotine Replacement Therapy (NRT) 1. Supporting Smokers to stop smoking The most effective method to quit smoking is by quitting
More informationMedication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019
Medication Management to Aid in Smoking Cessation Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 1 Learning Objectives: Review the prevalence of tobacco use. Describe tools
More informationPharmacotherapy for Tobacco Dependence Treatment
Pharmacotherapy for Tobacco Dependence Treatment Nancy Rigotti, MD Professor of Medicine, Harvard Medical School Director, Tobacco Research and Treatment Center, Massachusetts General Hospital nrigotti@partners.org
More informationTreating Tobacco Use and Dependence
Treating Tobacco Use and Dependence October 26, 2017 Great Plains Quality Improvement Network 1 Treating Tobacco Use and Dependence: Agenda Brief history and developmental process Facts about Tobacco Clinical
More informationTobacco Dependence Treatment: A Resource Guide. Last Update: 06/2013
Tobacco Dependence Treatment: A Resource Guide Last Update: 06/2013 1 Nicotine Replacement Therapy, combined with some form of social support or coaching can double, triple, or even quadruple your chances
More informationStrategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings
Strategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings Antoine Douaihy, MD Associate Professor of Psychiatry University of Pittsburgh School of Medicine
More informationMeasure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health
Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationPHARMACOTHERAPY OF SMOKING CESSATION
PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure
More information8/26/17. Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery. Cancer in the United States
Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery Cancer in the United States CDC and ASCO: Cancer leading cause of death in 22 states In 2033:
More informationTobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH
Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties
More informationSmoking Cessation: A readily modifiable risk factor
Robert L. Keith MD FCCP Associate Professor of Medicine Medical Director of Respiratory Therapy Eastern Colorado Health Care System University of Colorado Denver Smoking Cessation: A readily modifiable
More informationAnnual Tobacco Report 2000
Louisiana Tobacco Control Program Annual Tobacco Report 2000 This report summarizes indicators of tobacco use among adults, pregnant women, and youth in the state of Louisiana, and is set to serve as a
More informationCommon Questions about Cancer
6 What is cancer? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. The cancer cells form tumors that destroy normal tissue. If cancer cells break away from
More informationAmerican Vaping Association
Vaping.info American Vaping Association Gregory Conley, J.D., M.BA. President American Vaping Association Research Fellow Heartland Institute Member -- Gregory Conley Consulting, LLC Twitter: @GregTHR
More informationDisclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures
Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional
More informationSmoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018
Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in
More informationDrug Use Evaluation: Smoking Cessation
Drug Use Research & Management Program Oregon State University, 3303 SW Bond Av CH12C, Portland, Oregon 97239-4501 Phone 503-947-5220 Fax 503-494-1082 Drug Use Evaluation: Smoking Cessation Tobacco cessation
More informationThe Kentucky Department for Public Health University of Kentucky College of Nursing Knox County Health Department Tobacco Cessation Survey, 2001
1. Are you or other health department staff involved in providing tobacco cessation programs? 2. If, what programs do you provide? a. Fresh Start (American Cancer Society) b. Freedom from Smoking (American
More informationUAMS Tobacco and Disease Symposium 2018 Session 2 Documentation and Coding for Tobacco Cessation Assessment and Counseling.
UAMS Tobacco and Disease Symposium 2018 Session 2 Documentation and Coding for Tobacco Cessation Assessment and Counseling November 16, 2018 Today s Presenter Gail Olin, MSHI, MSN, RN, CPHQ, CPC, CHSRAP
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process
Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES:
More informationIan Landry, MPH Beth Schmidt, MSPH
Mary Charlton, PhD Bobbi Matt, CTR Mary Anne Lynch, MPH Vivien Chen, PhD Ian Landry, MPH Beth Schmidt, MSPH Response to EGFR inhibitors is poorer among Stage IV colorectal cancer (CRC) patients with KRAS
More informationM C acomb ounty Tobacco Treatment Toolkit. for Physicians
M C acomb ounty Tobacco Treatment Toolkit for Physicians 43525 Elizabeth Rd. Mt. Clemens, MI 48043-1078 (586) 469-5373 www.macombtobaccoprevention.com Dear Physician/Clinician, The tobacco epidemic is
More informationTobacco Cessation & Living Tobacco-Free After Cancer. Linda Hancock, FNP, PhD VCU Wellness Resource Center
Tobacco Cessation & Living Tobacco-Free After Cancer Linda Hancock, FNP, PhD VCU Wellness Resource Center Introductions Clickers to poll the room and find out something about the people who attended but
More informationSmoking Cessation A Clinicians Perspective. Jeff Wilson, MD
Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes
More informationIOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax
IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA 50315 (515) 974-3131 Fax 1-866-626-0216 Brett Faine, Pharm.D. Larry Ambroson, R.Ph. Casey Clor, M.D. Mark Graber, M.D.,
More informationPharmacologic Therapy for Tobacco Use & Dependence
Pharmacologic Therapy for Tobacco Use & Dependence Thomas Gauvin, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 Learning Objectives Understand the 7 first line medications
More informationECHO Clinics. Schedule and Curriculum Topics. Tuesdays 12:00 1:00 pm. Date Topic Presenter. Cessation: An Overview Part 2
ECHO Clinics Schedule and Curriculum Topics Tuesdays 12:00 1:00 pm Date Topic Presenter Tuesday, September 19, 2017 Cessation: An Overview Part 1 Tuesday, September 26, 2017 Neurobiology of Nicotine Dependence
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More information